A)  To develop an integrated neuromuscular model that describes the physiology of healthy versus impaired human gait (WP2)

B)  To design and manufacture personalised modular exoskeletons that compensate for SCI impairments (WP3)

C)  To develop personalised human inspired neuro-muscular controllers for the wearable exoskeletons (WP4)

D)  To optimise the design & control, and bi-directional symbiotic man-machine interaction of wearable exoskeletons (WP5)

E)  To determine the safety and functionality of the personalised SYMBITRON wearable exoskeletons in a clinical study (WP6)

F) To disseminate key findings to relevant stakeholders and to secure IP protection and exploitation of valuable innovatins (WP7)

Symbitron objectives